These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Where are we with postmenopausal hormone therapy in 2005? Lam PM; Chung TK; Haines C Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243 [TBL] [Abstract][Full Text] [Related]
29. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
30. Postmenopausal hormones. Hormone therapy: what happened? Our assumptions about taking hormones after menopause have mostly been dashed. How did we get it so wrong? Harv Womens Health Watch; 2003 Nov; 11(3):2-4. PubMed ID: 14633477 [No Abstract] [Full Text] [Related]
31. Postmenopausal hormone therapy: a reversal of fortune. Michels KB; Manson JE Circulation; 2003 Apr; 107(14):1830-3. PubMed ID: 12695280 [No Abstract] [Full Text] [Related]
33. The new hormone therapy problem: do we solve it with long-cycle progesterone therapy? Ravnikar V Menopause; 2005; 12(6):664-7. PubMed ID: 16278608 [No Abstract] [Full Text] [Related]
34. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850 [No Abstract] [Full Text] [Related]
36. Landmark hormone replacement therapy study stopped after finding more harms than benefits. Rollins G Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323 [No Abstract] [Full Text] [Related]
37. [Hormone replacement therapy and cancer risk]. Matsushita H; Wakatsuki A Nihon Rinsho; 2012 Jun; 70 Suppl 4():805-9. PubMed ID: 23156354 [No Abstract] [Full Text] [Related]
38. Impact of metabolism on the safety of estrogen therapy. Prokai-Tatrai K; Prokai L Ann N Y Acad Sci; 2005 Jun; 1052():243-57. PubMed ID: 16024767 [TBL] [Abstract][Full Text] [Related]
39. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens]. Meuwissen JH; Klinkhamer PJ; Brölmann HA; Wiegerinck MA Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1473. PubMed ID: 8361563 [No Abstract] [Full Text] [Related]
40. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]